Potential Role of the mTORC1-PGC1α-PPARα Axis under Type-II Diabetes and Hypertension in the Human Heart
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24108629 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Tianyu Hang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Diabetes and Vascular Pathology, IIS-Fundación Jiménez Díaz, Universidad Autónoma, 28040 Madrid, Spain. Hauptthemen laut MEDLINE: Hypertension, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Comunidad de Madrid and European Regional Development Fund, Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Type-2 diabetes (T2DM) and arterial hypertension (HTN) are major risk factors for heart failure. Importantly, these pathologies could induce synergetic alterations in the heart, and the discovery of key common molecular signaling may suggest new targets for therapy. Intraoperative cardiac biopsies were obtained from patients with coronary heart disease and preserved systolic function, with or without HTN and/or T2DM, who underwent coronary artery bypass grafting (CABG). Control (n = 5), HTN (n = 7), and HTN + T2DM (n = 7) samples were analysed by proteomics and bioinformatics. Additionally, cultured rat cardiomyocytes were used for the analysis (protein level and activation, mRNA expression, and bioenergetic performance) of key molecular mediators under stimulation of main components of HTN and T2DM (high glucose and/or fatty acids and angiotensin-II). As results, in cardiac biopsies, we found significant alterations of 677 proteins and after filtering for non-cardiac factors, 529 and 41 were changed in HTN-T2DM and in HTN subjects, respectively, against the control. Interestingly, 81% of proteins in HTN-T2DM were distinct from HTN, while 95% from HTN were common with HTN-T2DM. In addition, 78 factors were differentially expressed in HTN-T2DM against HTN, predominantly downregulated proteins of mitochondrial respiration and lipid oxidation. Bioinformatic analyses suggested the implication of mTOR signaling and reduction of AMPK and PPARα activation, and regulation of PGC1α, fatty acid oxidation, and oxidative phosphorylation. In cultured cardiomyocytes, an excess of the palmitate activated mTORC1 complex and subsequent attenuation of PGC1α-PPARα transcription of β-oxidation and mitochondrial electron chain factors affect mitochondrial/glycolytic ATP synthesis. Silencing of PGC1α further reduced total ATP and both mitochondrial and glycolytic ATP. Thus, the coexistence of HTN and T2DM induced higher alterations in cardiac proteins than HTN. HTN-T2DM subjects exhibited a marked downregulation of mitochondrial respiration and lipid metabolism and the mTORC1-PGC1α-PPARα axis might account as a target for therapeutical strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Diabetes and Vascular Pathology, IIS-Fundación Jiménez Díaz, Universidad Autónoma, 28040 Madrid, Spain.
- Biomedical Research Network on Diabetes and Associated Metabolic Disorders (CIBERDEM), Carlos III National Health Institute, 28029 Madrid, Spain.
- Liver Disease Lab, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), 48160 Derio, Spain.
- Biomedical Research Network on Liver and Digestive Diseases (CIBERehd), Carlos III National Health Institute, 28029 Madrid, Spain.
- Proteomics Platform, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), 48160 Derio, Spain.
- Cardiovascular Surgery Department, Fundación Jiménez Díaz Hospital, 28040 Madrid, Spain.
ORCID-Profile: Tianyu Hang, Jairo Lumpuy-Castillo, Naroa Goikoetxea-Usandizaga, Gonzalo Aldámiz, Félix Elortza, Malu Martínez-Chantar, José Tuñón, Óscar Lorenzo
Förderung
- Instituto de Salud Carlos III
- Comunidad de Madrid and European Regional Development Fund
- Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas
- REACT-EU
- Carlos III
- Biobank
- Ciberdem
Zitieren
APA
Hang, T., Lumpuy-Castillo, J., Goikoetxea-Usandizaga, N., Azkargorta, M., Aldámiz, G., Martínez-Milla, J., Forteza, A., Cortina, J. M., Egido, J., Elortza, F., Martínez-Chantar, M., Tuñón, J., & Lorenzo, Ó. (2023). Potential Role of the mTORC1-PGC1α-PPARα Axis under Type-II Diabetes and Hypertension in the Human Heart. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24108629
Vancouver
Hang T, Lumpuy-Castillo J, Goikoetxea-Usandizaga N, Azkargorta M, Aldámiz G, Martínez-Milla J, et al. Potential Role of the mTORC1-PGC1α-PPARα Axis under Type-II Diabetes and Hypertension in the Human Heart. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24108629
BibTeX
@article{Hang2023,
author = {Hang, Tianyu and Lumpuy-Castillo, Jairo and Goikoetxea-Usandizaga, Naroa and Azkargorta, Mikel and Aldámiz, Gonzalo and Martínez-Milla, Juan and Forteza, Alberto and Cortina, José M and Egido, Jesús and Elortza, Félix and Martínez-Chantar, Malu and Tuñón, José and Lorenzo, Óscar},
title = {Potential Role of the mTORC1-PGC1α-PPARα Axis under Type-II Diabetes and Hypertension in the Human Heart},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24108629}
}
EUVIMED